Certified by Founder
Lodge
Asimov
start up
United States
- Boston, Massachusetts
- 09/01/2023
- Series B
- $200,000,000
Asimov builds tools to program living cells. By integrating mammalian synthetic biology, computer-aided design, and machine learning, our multi-disciplinary team is advancing the design and manufacture of biologics and gene therapies.
- Industry Biotechnology Research
- Website https://www.asimov.com/
- LinkedIn https://www.linkedin.com/company/asimov/
Derapi | $7,000,000 | (Feb 4, 2026)
Naoma AI | $440,000 | (Feb 4, 2026)
enclaive | $4,849,418 | (Feb 4, 2026)
OneDome | $25,000,000 | (Feb 4, 2026)
ecovia I bio | Undisclosed Amount | (Feb 4, 2026)
AIRRIVED | $6,100,000 | (Feb 4, 2026)
MaiaEdge | $20,000,000 | (Feb 4, 2026)
Mitra EV | $27,000,000 | (Feb 4, 2026)
Arbor(US) | $6,300,000 | (Feb 4, 2026)
Graici | $7,500,000 | (Feb 4, 2026)
Linq | $20,000,000 | (Feb 3, 2026)
Breezy | $10,000,000 | (Feb 3, 2026)